The St. Jude Red Frog Proton Therapy Center is the world’s only proton therapy center dedicated solely to children.
On the research front, we are seeing equally exciting progress. St. Jude has announced significant research advancements impacting patients with solid tumors, brain tumors, leukemias, sickle cell disease and infectious diseases, among others. Cutting-edge research facilities are in the works to further explore the origins of childhood cancer and drive better treatments.
A new world-class Data Center will support these efforts as well as our St. Jude Cancer Predisposition Program, which identifies children who are at increased genetic risk for cancer through genomic sequencing. And just this year, as part of the commitment to develop and educate the next generation of scientific leaders, St. Jude established the St. Jude Graduate School of Biomedical Sciences.
This is just the beginning of our commitment to advance our mission of finding cures and saving children. In total, we are investing $9 billion over 6 years to support and operate St. Jude and to expand our lifesaving mission. You can read the latest about these plans in the summer 2017 issue of Promise magazine.
In short, the dedicated faculty and staff of St. Jude are as committed today as they have been since the beginning of our mission to find the cures that will end the scourge of childhood cancer and other diseases that threaten the lives of children everywhere. Without the resources provided by generous and caring donors and volunteers like you, we could not dare to undertake such bold new plans. Your support enables us to dream, and thanks to you, St. Jude has become the leading private funder of pediatric cancer research.
I know that together, we can reach the day that Danny dreamed of: a day when no child will die in the dawn of life.
You, too, can make a difference for St. Jude kids.
Read more inspiring stories
-
PFCC offers mom a way to help others, give back
Caregiver reflects on giving back to St. Jude
-
Journey to the Jude: Joseph Gutierrez
The Journey to the Jude series highlights how St. Jude employees developed a passion for their careers and how that journey translates to their current roles. Read about Joseph Gutierrez, a pediatric oncology nurse
-
Cultural navigator brings new level of support to international families
Cultural navigation is important in providing exceptional care for international families at St. Jude. Find out how the hospital helps these families.
-
Challenges Can’t Keep Jolly Down
Jolly Green tackles severe aplastic anemia thanks to St. Jude, faith, and family. Read his story.
-
Patient reflects on 60th anniversary as childhood cancer survivor
Patient reflects on her 60th anniversary as a childhood cancer survivor
-
From Pain Crises to Good Vibes
Rashawn Hendrix
-
Patient finds support, help and hope for Friedrich’s ataxia
Taylor Hurdle is taking part in a clinical trial for Friedreich’s ataxia at St. Jude Children’s Research Hospital.
-
Finding Hope in Clinical Trials
A medulloblastoma clinical trial offered hope to 7-year-old Kinlee Johnson and her family. Learn more.
-
Family chooses St. Jude because of SAMD9/SAMD9L researcher
Family chooses St. Jude for care because of its expertise in SAMD9/SAMD9L syndrome.
-
Participating in clinical trials to help cure the next person
Patients like Corey Luellen have benefitted from gene editing for sickle cell disease. Luellen participated in a clinical trial for the treatment because he wanted to help others.
-
Insights Learned Through Cancer Experience Now Help Others
St. Jude survivor Tristan Elsener has survived multiple bouts of cancer. He and his family have gained insights that can help others. Learn about the Caregivers Share podcast.
-
Research may help Camille take her first steps
Research conducted by the Center for Experimental Neurotherapeutics may help patients like Camille, who has type 2 spinal muscular atrophy, gain the ability to walk.
-
Surviving childhood cancer is just the beginning of Darshana’s story
Darshana Magan survived cancer 30 years ago, but her treatment caused long-term health issues. Read how she cares for her health and encourages other survivors.
-
Molecular diagnostics give Fletcher what some thought impossible: a diagnosis and treatment plan
Molecular diagnostics give Fletcher Fazenbaker what some thought impossible: a diagnosis and treatment plan for infant-type hemispheric glioma (IHG), a subtype of high-grade glioma — a rare brain tumor — that was not classified by the World Health Organization’s brain tumor classification guide until 2021
-
Perspective from the courtside
USA Pickleball Association President Jack Thomas knows the good work of USAPA’s designated charity, St. Jude. His grandson was a patient.